Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB26FNMNE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,042
Award facts
- Contract value 100% obligated
- $82,041.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $82,041.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 mL vials. The award, issued on October 29, 2025, with an ultimate completion date of November 20, 2025, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling value and extends through December 31, 2036.
DMS Pharmaceutical Group's selection reflects its established role as a critical supplier within the Department of Defense's military healthcare supply chain. The company's product portfolio encompasses oncology treatments, immunosuppressants, biologics, vaccines, and specialty pharmaceuticals serving military medical facilities worldwide. As a regional prime vendor contractor under the $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group has demonstrated substantial federal contracting activity and consistent performance across multiple therapeutic categories, positioning it as a key pharmaceutical supplier supporting DoD healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FNMNE?
SPE2DB26FNMNE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FNMNE worth?
The government has obligated $82,042 on SPE2DB26FNMNE.
Is contract SPE2DB26FNMNE an order under another contract?
Yes. SPE2DB26FNMNE is a delivery order under SPE2DB25D9348, an indefinite delivery contract.
Was contract SPE2DB26FNMNE competed?
The extent of competition for SPE2DB26FNMNE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award